Serum sickness with furazolidone.
Two cases of serum sickness from furazolidone (Furoxona), prescribed for giardiasis in Latin America, are described. No previous case of serum sickness related to this drug has been reported in the United States. Tartrazine (yellow dye number 5), a component of furazolidone tablets (Furoxona) manufactured in Latin America countries but no longer included in the drug (Furoxone) in the United States is suggested as a possible cause of serum sickness.
D000328:Adult; D005664:Furazolidone / Q000009:adverse effects* / Q000627:therapeutic use; D005873:Giardiasis / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D012713:Serum Sickness / Q000139:chemically induced*
D005664:Furazolidone